Lipoprotein‐Based Nanocatalyst Enables Targeted Treatment of APAP‐Induced Liver Injury via Enhanced Macropinocytosis
1. 请及时下载文件确认是否正确, 系统将在 2025-06-28 23:21:29 删除文件
2. 如若文件有误请驳回应助文件, 求助状态即回到求助中
3. 如若文件正确请及时点击确认, 若超过时后系统自动默认为已完结
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
Y Chen, G Jiang, Y Huang, S Song, H Fu…
Advanced …, 2025
Wiley Online Library
Drug‐induced liver injury (DILI), predominantly caused by acetaminophen (APAP) overdose, is characterized by excessive reactive oxygen species (ROS) production and subsequent hepatocyte necrosis. Although N‐acetylcysteine (NAC) remains the only approved treatment, its effectiveness is limited by a narrow therapeutic time window and reduced efficacy in advanced cases. To address these limitations, an innovative therapeutic approach is developed utilizing ceria's antioxidant properties. In this study, a reconstituted …
